Sysmex RDCA is endeavoring to create new clinical value for personalized medicine through open innovation – generating synergy by combining the technology and knowledge possessed by universities and research institutes with our own.

Our R&D Activities Through Open Innovation Include:

Research and Development of applications in a variety of disease fields using our technology platforms such as for genes, cells and proteins.

Disease Fields

  • Cancer
  • Chronic Disease
  • Infectious Disease
  • Immunological Disease
  • Cardiovascular Disease
  • Blood

R&D of elemental technologies in the area such as biology, chemistry, information science, electronic engineering etc.

Knowledge Underpinning R&D

Medical Engineering

Information Science

Electronic Engineering


Applied Physics